Amgen Inc. (AMGN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 04:00PM EDT. Market open.
| Previous Close | 244.77 |
| Open | 244.06 |
| Bid | 247.10 x 800 |
| Ask | 247.20 x 900 |
| Day's Range | 243.01 - 247.63 |
| 52 Week Range | 198.64 - 258.45 |
| Volume | |
| Avg. Volume | 3,188,568 |
| Market Cap | 139.408B |
| Beta (5Y Monthly) | 0.59 |
| PE Ratio (TTM) | 25.51 |
| EPS (TTM) | 9.70 |
| Earnings Date | Apr 25, 2022 - Apr 29, 2022 |
| Forward Dividend & Yield | 7.76 (3.19%) |
| Ex-Dividend Date | May 16, 2022 |
| 1y Target Est | 249.25 |
- Zacks
Novartis (NVS) Cosentyx Gets Positive CHMP Opinion for JIA
Novartis (NVS) Cosentyx gets a positive CHMP recommendation for the indication of juvenile idiopathic arthritis.
- Motley Fool
Could This Biosimilar Drug Candidate Create a Blockbuster for Amgen?
J&J's immunology mega-blockbuster loses exclusivity in the U.S. next year -- and Amgen's biosimilar is ready to capitalize.
- Zacks
Mirati (MRTX) Seeks EU Nod for Adagrasib to Treat Lung Cancer
Mirati (MRTX) seeks a nod for its lung cancer candidate adagrasib in the European Union. A regulatory filing in the United States is currently under the FDA review with decision pending this year-end.
© 2022 Yahoo. All rights reserved.
